| Bioactivity | Metenolone enanthate (Methenolone enanthate), an ester derivative of Methenolone, is an androgen receptor (AR) agonist and long-acting dihydrotestosterone (DHT) anabolic steroid (AAS) agent. Metenolone enanthate is available as an injection or as an oral formulation, and the injection is regarded as having a higher bioavailability. Metenolone enanthate can suppress the hypothalamic-pituitary-gonadal axis and produce reversible hypogonadism and infertility. Metenolone enanthate can be used for researching breast cancer and anemia due to bone marrow failure[1][2][3]. | ||||||||||||
| Target | Androgen receptor | ||||||||||||
| In Vivo | Metenolone enanthate (0.5 mg/kg; IP, 5 times a week for 4 weeks) causes left ventricular hypertrophy in female rats[1]. Animal Model: | ||||||||||||
| Name | Metenolone enanthate | ||||||||||||
| CAS | 303-42-4 | ||||||||||||
| Formula | C27H42O3 | ||||||||||||
| Molar Mass | 414.62 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Ozdemir O, et al. Side effect of metenolone enanthate on rats heart in puberty: morphometrical study. Exp Toxicol Pathol. 2013 Sep;65(6):745-50. [2]. Metenolone enanthate [3]. Kennedy BJ, et al. Effect of methenolone enanthate (NSC-64967) in advanced cancer of the breast. Cancer. 1968 Feb;21(2):197-201. |
Metenolone enanthate
CAS: 303-42-4 F: C27H42O3 W: 414.62
Metenolone enanthate (Methenolone enanthate), an ester derivative of Methenolone, is an androgen receptor (AR) agonist a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.